- Austria (Website)
- Czech Republic (Website)
- Denmark (Website)
- Finland (Website)
- France (Website)
- Germany (Website)
- Italy (Website)
- Ivory Coast
bioMérieux, Inc. Sponsored Cystic Fibrosis Webinar
May 29 | 2 PM ET | Trends in Bacterial Resistance and New Antibiotic Treatments for Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis | Presented by: Joseph L. Kuti, PharmD, FIDP
Chronic pulmonary infections in cystic fibrosis patients is an ongoing challenge. The emergence of multi-drug-resistant mucoid organisms, such as Pseudomonas aeruginosa, has further complicated these infections.
- List problem bacterial pathogens in CF patients and other current resistance trends in this population
- Describe challenges with microbiological identification and susceptibility testing of CF pathogens
- Identify new antibiotics that may play a role in the treatment of acute pulmonary exacerbations in patients with CF
Professional Acknowledgment for Continuing Education (P.A.C.E.®) credits will be offered.
bioMérieux, Inc. is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. CE Broker in the state of Florida may not accept P.A.C.E. credits for this course.